Patents by Inventor Aniruddha M. Railkar

Aniruddha M. Railkar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11998640
    Abstract: Room-temperature stable dosage forms for oral delivery of calcitonin are disclosed herein. Dosage forms for oral delivery of calcitonin with low water content are also disclosed herein. Further disclosed herein are methods for producing such room-temperature stable dosage forms and low-water content dosage forms. Methods of treatment comprising the administration of such room-temperature stable dosage forms and low-water content dosage forms are also disclosed herein.
    Type: Grant
    Filed: February 18, 2022
    Date of Patent: June 4, 2024
    Assignees: Park Therapeutics, Inc., Enteris Biopharma, Inc.
    Inventors: James P. Gilligan, George R. Maurer, Aniruddha M. Railkar, Phillip Bauer, Thomas A. Daggs, Paul P. Shields
  • Publication number: 20230000779
    Abstract: Room-temperature stable dosage forms for oral delivery of calcitonin are disclosed herein. Dosage forms for oral delivery of calcitonin with low water content are also disclosed herein. Further disclosed herein are methods for producing such room-temperature stable dosage forms and low-water content dosage forms. Methods of treatment comprising the administration of such room-temperature stable dosage forms and low-water content dosage forms are also disclosed herein.
    Type: Application
    Filed: February 18, 2022
    Publication date: January 5, 2023
    Inventors: James P. Gilligan, George R. Maurer, Aniruddha M. Railkar, Phillip Bauer, Thomas A. Daggs, Paul P. Shields
  • Patent number: 11285113
    Abstract: Room-temperature stable dosage forms for oral delivery of calcitonin are disclosed herein. Dosage forms for oral delivery of calcitonin with low water content are also disclosed herein. Further disclosed herein are methods for producing such room-temperature stable dosage forms and low-water content dosage forms. Methods of treatment comprising the administration of such room-temperature stable dosage forms and low-water content dosage forms are also disclosed herein.
    Type: Grant
    Filed: February 5, 2019
    Date of Patent: March 29, 2022
    Assignees: TAURUS DEVELOPMENT COMPANY LLC, ENTERIS BIOPHARMA, INC.
    Inventors: James P. Gilligan, George R. Maurer, Aniruddha M. Railkar, Phillip Bauer, Thomas A. Daggs, Paul P. Shields
  • Publication number: 20190192442
    Abstract: Room-temperature stable dosage forms for oral delivery of calcitonin are disclosed herein. Dosage forms for oral delivery of calcitonin with low water content are also disclosed herein. Further disclosed herein are methods for producing such room-temperature stable dosage forms and low-water content dosage forms. Methods of treatment comprising the administration of such room-temperature stable dosage forms and low-water content dosage forms are also disclosed herein.
    Type: Application
    Filed: February 5, 2019
    Publication date: June 27, 2019
    Inventors: James P. Gilligan, George R. Maurer, Aniruddha M. Railkar, Phillip Bauer, Thomas A. Daggs, Paul P. Shields
  • Publication number: 20080090902
    Abstract: The present invention relates to a composition of a phenylalkylamino carbamate compound that results in improved stability, wherein the composition comprises a phenylalkylamino carbamate compound in a mixture with an effective amount of one or more excipients wherein at least one excipient is dibasic calcium phosphate dihydrate.
    Type: Application
    Filed: October 8, 2007
    Publication date: April 17, 2008
    Inventors: Ramendra N. Pandey, Tracey Mascaro, Aniruddha M. Railkar, James McCool, Hinton Clark, Stanley Altan